Gifts to doctors by pharmaceutical companies are not just a regulatory problem but an ethical one. Discuss with reference to conflict of interest in the medical profession.

A conflict of interest arises when a doctor's personal gain competes with the duty owed to the patient. The Uniform Code for Pharmaceutical Marketing Practices (UCPMP) 2024 bars gifts, monetary benefits and hospitality to doctors and their families [1]. Yet the practice continues, because it is as much a failure of professional ethics as of rules.

Regulatory dimension

• Self-regulatory roots: UCPMP 2015 was voluntary. Complaints were forwarded to industry associations, so firms were judged by their own trade bodies [2].
• Mild penalties: The 2024 Code added Ethics Committees (ECPMPs) and Ethics Officers [3], with appeals going to the Department of Pharmaceuticals (DoP). Its own sanction, however, is largely a corrective media statement, and heavier action depends on "existing laws" [1].
• Split jurisdiction: UCPMP binds only the giver. The doctor who accepts answers to State Medical Councils under the IMC (Professional Conduct, Etiquette and Ethics) Regulations, 2002 [4]. There is no link between the two routes.

Ethical dimension: conflict of interest

• Fiduciary breach: Patients cannot judge a prescription for themselves. Gifts can tilt doctors towards costly brands over cheaper generics, which violates beneficence and non-maleficence.
• Erosion of trust: Hidden inducements weaken trust between doctor and patient. This is why medical ethics regulations restrict doctors from accepting gifts from the pharma industry [4].
• Justice: Patients bear higher out-of-pocket costs for brand-driven prescribing, and the burden falls hardest on the poor.
• Voiceless victims: The government has reported no recent demand from patient groups for a mandatory code [2]. The party that is harmed cannot see the transaction.
• Limits of rules: A code can ban the gift, but only a professional conscience can refuse it. Compliance without integrity just moves inducements into forms such as "conferences".

Way forward

• Statutory backing: The Srinivas Committee (Oct 2026) has been asked to suggest a legal framework [5].
• Joint enforcement: Every proven UCPMP violation should be referred to the NMC and State Medical Councils.
• Global benchmark: India can adopt the WHO Ethical Criteria (WHA41.17), which require generic names on promotional material [6]. This would also strengthen Jan Aushadhi.
• Ethics training: Ethics modules in medical curricula, along with public disclosure of industry payments.

Gifts to doctors are a regulatory gap and an ethical lapse at the same time. Firm laws can deter the giver, but professional integrity must restrain the taker. Combining legal enforcement with a culture of medical ethics will protect patients' Right to Health under Article 21 and advance SDG 3.